(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Health care stocks were mixed pre-bell Monday. The Health Care SPDR (XLV) was up 0.12%, and the iShares NASDAQ Biotechnology Index (IBB) was recently 0.20%...
US stocks were set for narrow gains Monday, extending previous session's gains after an inflation expectation gauge showed a slight easing. Dow Jones...
Epizyme (EPZM) has an average rating of buy and price targets ranging from $0.60 to $8, according to analysts polled by Capital IQ. (MT Newswires covers...
Acutus Medical (AFIB) shares nearly doubled after the company launched an expanded suite of left-heart access products. Evofem Biosciences (EVFM) shares...
Epizyme (EPZM) has agreed to be acquired by French pharmaceutical company Ipsen for a total of $247 million, Ipsen said Monday. Under the terms, Ipsen's...
Epizyme (EPZM) has an average rating of outperform and price targets ranging from $0.60 to $8, according to analysts polled by Capital IQ. (MT Newswires...
HUTCHMED (HCM) said Wednesday that the Health Commission and Medical Products Administration of Hainan Province has approved the use of Tazverik within the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...